Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLX-028914 in Allergic Rhinitis – Allergen Challenge Cross-over Study
2008-001179-30Phase 2Completed
- Sponsor
- Orexo AB
- Start
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of HT-0712 in allergic rhinitis (AR) (3 arms), sponsored by Orexo AB. Started May 2008; status: completed.
02
Drugs
HT-0712
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on 2008-001179-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001179-30.